BSE filing, NSE: VIRAT. Summary written from the filing by ALFA Finder's alert engine.
Virat Industries Ltd: key numbers
- Share price
- ₹416.00
- Market cap
- ₹604.2 Cr
- Revenue (annual)
- ₹26.79 Cr
- Net profit (annual)
- ₹4.94 Cr
- P/E (TTM)
- 97.6×Sector 49.5×
- Promoter holding
- 74.55%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Virat Industries Ltd
All →Virat Industries Other Announcement
The Company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI (LODR) Regulations for the quarter ended September 30, 2026.
Virat Industries Management Change
Brahm Virat Industries announced the resignation of its Chief Financial Officer, Mr. Bhavik Maisuria, effective December 31, 2026. The board also authorized preliminary strategic exploration initiatives.
Virat Industries Board Meeting Date
Brahm Virat Industries scheduled a Board Meeting on 8th October 2026 to discuss business operations, strategic initiatives, and future growth opportunities.
Virat Industries Annual General Meeting
Brahm Virat Industries held an EGM on October 1, 2026. Shareholders considered the approval of a material related party transaction involving a 70.28% equity acquisition.
Virat Industries Management Change
Mr. Bhavik Maisuria has resigned as the Chief Financial Officer (CFO) of Brahm Virat Industries Corporation Limited. His resignation is effective from December 31, 2026.
Virat Industries Annual Report
The company submitted a revised Annual Report for FY 2025-26. The modifications rectify minor typographical and rounding-off errors without impacting financial results.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.